IHCL Q4 net profit rises 25% to ₹522 crore


Puneet Chhatwal, Managing Director & CEO, IHCL, says, “Q4 marks 12 consecutive quarters of record performance with consolidated hotel segment revenue reporting a strong growth of 13%, resulting in EBITDA margin of 38.5%.

Puneet Chhatwal, Managing Director & CEO, IHCL, says, “Q4 marks 12 consecutive quarters of record performance with consolidated hotel segment revenue reporting a strong growth of 13%, resulting in EBITDA margin of 38.5%.
| Photo Credit: JOTHI RAMALINGAM B

Indian Hotels Company Ltd (IHCL) for the fourth quarter ended March 31, 2025 reported 25% Year on Year (YoY) growth in net profit at ₹522 crore according to a statement by the company.

Quarterly revenue grew 27% YoY to ₹2487 crore.

The board has recommend a dividend of ₹2.24 per share.

For FY25 the company’s net profit grew 52% YoY to ₹1,908 crore while revenue rose 23% to ₹8,565 crore. 

The company said the full year & Q4 PAT before exceptional items was ₹1,603 crore and ₹525 crore respectively.

Puneet Chhatwal, Managing Director & CEO, IHCL, said, “Q4 marks twelve consecutive quarters of record performance with consolidated hotel segment revenue reporting a strong growth of 13% resulting in EBITDA margin of 38.5%.”

“The consolidated double -digit revenue growth for the year was driven by strong same store performance, 40% increase in New Businesses and not like for like growth. IHCL set a new benchmark with 74 signings and 26 openings this fiscal and over 95% of these signings were capital light,” he said.

He said FY26 IHCL will invest over ₹ 1,200 crores” towards the continued comprehensive asset management & upgradation program and greenfield projects with the focus on the iconic brand Taj and digital capabilities. 

“Looking ahead at FY26, IHCL is poised to continue double-digit revenue growth, driven by strong same-store performance, sustained momentum in New Businesses and 30 new hotel openings. The sector outlook remains strong, with demand outpacing supply, a recovery of foreign tourist arrivals and steady momentum across leisure, social and MICE segments,” he added. 



Source link

  • Related Posts

    Lupin, China’s SUP ink pact for COPD drug Tiotropium DPI

    Lupin has signed a license and supply agreement with Sino Universal Pharmaceuticals (SUP) for commercialisation of chronic obstructive pulmonary disease drug Tiotropium Dry Powder Inhaler, 18 mcg/capsule, in the Chinese…

    Continue reading
    India to export 150 locomotives to Africa worth over ₹3,000 crore

    “These locomotives are fitted with Distributed Power Wireless Control System, or DPWCS, for synchronised operations and superior freight handling,” a Railways Ministry spokesperson said. Photo: https://www.wabteccorp.com/ India will supply 150…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *